Mount Sinai Hospital, Canada

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Mount Sinai Hospital, Canada sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 4 completed later-stage tilt upper quartile by trial count

Mount Sinai Hospital, Canada: 7 sponsored US clinical trials, 2 recruiting.

Mount Sinai Hospital, Canada sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Adult Soft Tissue Sarcoma, with 1 trials.

Upper-quartile sponsor footprint

Mount Sinai Hospital, Canada sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING NA

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

NCT06004739
RECRUITING

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

NCT05347238
ACTIVE NOT RECRUITING Phase 3

Preoperative vs Postoperative IMRT for Extremity/Truncal STS

NCT02565498
COMPLETED NA

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)

NCT04153864
COMPLETED

Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension

NCT04402645
COMPLETED NA

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial

NCT01788527
COMPLETED NA

Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol.

NCT00675363

Phase Distribution

PhaseTrial count
Phase 3 1

Therapeutic Areas

Adult Soft Tissue Sarcoma 1
Infectious Disease 1
Perinatal Depression 1
Critical Illness 1
Neonatal Hypotension 1
Extreme Prematurity 1
Late-Onset Neonatal Sepsis 1

Where Mount Sinai Hospital, Canada enrollment is open (later-stage tilt)

2 recruiting of 7 indexed (29% open); 4 completed (57%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Adult Soft Tissue Sarcoma (1 trial), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Mount Sinai Hospital, Canada: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Mount Sinai Hospital, Canada sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Mount Sinai Hospital, Canada3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Mount Sinai Hospital, Canada sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Mount Sinai Hospital, Canada sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Mount Sinai Hospital, Canada page

7 registered trials is a research-attention snapshot, not an endorsement of Mount Sinai Hospital, Canada or any single study.

  • 2 of Mount Sinai Hospital, Canada's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Adult Soft Tissue Sarcoma is the condition Mount Sinai Hospital, Canada studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Adult Soft Tissue Sarcoma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mount Sinai Hospital, Canada pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.